Collaboration will fast track the development and scale-up of Evonetix’s desktop DNA writer towards commercialisation and first product Technology will help facilitate the rapidly growing multibillion-dollar synthetic biology industry EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced a collaboration with leading, global high-performance […]
continue reading